Rwanda

Overview

Rwanda has made incredible strides to control the AIDS epidemic. The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) was witness to this accomplishment. We began working in Rwanda in 2000, developing a country office and working hand-in-hand alongside the Ministry of Health for almost 20 years. As Rwanda leapt through its gains, EGPAF moved from hands-on country-side support and leadership, to resourceful technical assistance and resource accommodation, as needed.

Our Work

Currently, EGPAF manages one award, funded by Johnson and Johnson. The New Horizons project focuses on supply chain management and specifically around quicker access to second and third line antiretroviral formulations for children and adolescents failing their first-line therapies. This project began in 2019.

Projects

Closed | 2021

New Horizons Project 2021

In 2021, the NH will transition to a new phase of New Horizons 2.0, EGPAF as a key implementing partner along with other current partners including Partnership for Supply Chain Management, Imperial Logistics, CIPHER Paediatric HIV Matters, Right to Care, and the Paediatric European Network for Treatment of AIDS.

Open | 2019 - 2023

New Horizons Study 2019 – 2023

Demographic Clinical, and Laboratory Characteristics and Outcomes of Pediatric Patients Who Ever Received Etravirine and/or Darunavir

The current activity proposes to collect cross-sectional demographic and clinical data at baseline and every six months for patients receiving DRV and/or ETR across participating New Horizons countries. This activity will comprise data abstraction of a key demographic, clinical, laboratory and case history indicators and outcomes on each patient who ever received DRV and/or ETR.

No Projects